Abstract:BACKGROUND:Cutaneous T cell lymphoma (CTCL) comprises a heterogeneous group of skin-homing T cell tumors. The small guanosine triphosphate effector p21-activated kinase 1 (PAK1) plays an important role in many fundamental cellular functions, including cell motility, proliferation, and apoptosis. The expression of PAK1 is up-regulated in several types of human cancers. However, little is known about the role of PAK1 in the pathogenesis of CTCL.OBJECTIVE:The aim of this study was to evaluate the expression pattern and underlying mechanism of PAK1 in CTCL.METHODS:Quantitative real-time polymerase chain reaction(qRT-PCR) was used to detect PAK1 mRNA expression in the peripheral blood mononuclear cells (PBMCs) of patients with CTCL. The expression of PAK1 protein in CTCL tumor tissues was determined by immunohistochemistry. CTCL cell lines were treated with a small molecule inhibitor of PAK1, p21-activated kinase inhibitor III (IPA3), at concentrations of 2, 3.5 and 5 μM for 24 h. Hut 78 and HH CTCL cells were transfected with lentiviral-based PAK1 gene knockdown vectors. We determined the effects of PAK1 knockdown on cell proliferation and apoptosis in CTCL cells by MTS assay and flow cytometry. Animal experiments were performed to investigate the effects of PAK1 knockdown on the growth of tumors in vivo. Transcriptomic sequencing was performed to detect the direct downstream targets of PAK1 silencing. Reverse transcription polymerase chain reaction and western blot analysis were applied to verify the results of the transcriptomic analysis.RESULTS:We detected PAK1 overexpression in PBMCs and skin lesions from patients with CTCL compared with benign inflammatory dermatoses (BID). Knockdown of PAK1 inhibited cell proliferation and promoted spontaneous apoptosis. In addition, the inhibitory effect of IPA3 was validated in the CTCL cell lines. Additionally, mice injected with PAK1-silenced cells presented with a decreased rate of tumor growth compared with the control groups. Moreover, the mRNA and protein expression of PUMA (BBC3) and p21 (CDKN1A) were increased in PAK1-silenced Hut 78 and HH cells.CONCLUSIONS:Our data indicated that PAK1 is upregulated in CTCL. PAK1 silencing induced apoptosis and inhibited cell growth by stimulating the expression of PUMA and p21. Thus, PAK1 may be a potential tumor marker and therapeutic target of CTCL.

Clinicopathological signature of p21-activated kinase 1 in prostate cancer and its regulation of proliferation and autophagy via the mTOR signaling pathway

Clinicopathological and cellular signature of PAK1 in human bladder cancer

p21-activated kinase signalling in pancreatic cancer: New insights into tumour biology and immune modulation

Inhibition of PAK1 suppresses pancreatic cancer by stimulation of anti-tumour immunity through down-regulation of PD-L1.

Targeted Inhibition of Mtor by BML-275 Induces Mitochondrial-Mediated Apoptosis and Autophagy in Prostate Cancer.

Activation of the Mammalian Target of Rapamycin Signalling Pathway in Prostate Cancer and Its Association with Patient Clinicopathological Characteristics

Reduced Expression of P21-Activated Protein Kinase 1 Correlates with Poor Histological Differentiation in Pancreatic Cancer

[Expression of PAK1 in Bladder Cancer and Its Influence on Invasion of Bladder Cancer Cells].

P21-activated Kinase 1 and Breast Cancer

Tumor-infiltrating Regulatory T Lymphocytes Orchestrate Oncogenic PAK1-conferred Immune Evasion in Clear-Cell Renal Cell Carcinoma

Unveiling RACK1: a key regulator of the PI3K/AKT pathway in prostate cancer development

PAK1-dependent MAPK Pathway Activation is Required for Colorectal Cancer Cell Proliferation

PAK1 Expression Determines Poor Prognosis and Immune Evasion in Metastatic Renal Cell Carcinoma Patients.

Molecular Pathways: Targeting P21-Activated Kinase 1 Signaling in Cancer--opportunities, Challenges, and Limitations.

The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling

PAK1 Overexpression Promotes Cell Proliferation in Cutaneous T Cell Lymphoma Via Suppression of PUMA and P21

Important Roles of PI3K/AKT Signaling Pathway and Relevant Inhibitors in Prostate Cancer Progression

SGK1 Inhibition Induces Autophagy-Dependent Apoptosis Via the Mtor-Foxo3a Pathway

FGF21 facilitates autophagy in prostate cancer cells by inhibiting the PI3K–Akt–mTOR signaling pathway

HKDC1 promotes autophagy and proliferation in pancreatic adenocarcinoma through interaction with PARP1 and poly(ADP-ribosyl)ation

PRKCI Negatively Regulates Autophagy Via PIK3CA/AKT–MTOR Signaling